GE Medical Systems recalled 29,225 units of the MAC VU360 Acquisition Trunk Cable and Module Holder on August 22, 2025. Users may incorrectly place the Acquisition Module, leading to cable damage and potential overheating. Affected devices were distributed globally, including the U.S. and several other countries.
If a user incorrectly places the Acquisition Module into the Acquisition Module Holder, it can result in excessive bending and wear of the Acquisition Trunk Cable. This is visible as a damaged sheath or exposed wires. If a damaged Acquisition Trunk Cable is not recognized and removed from service, the cable can overheat with continued use.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact GE Medical Systems, LLC or your healthcare provider for instructions. Notification method: Letter
The recall involves the MAC VU360 Acquisition Trunk Cable and Module Holder, Model Number 2030360-001, Product Codes VU2 and VU4. The devices were distributed worldwide, including the U.S., Australia, Canada, and European countries.
Improper placement of the Acquisition Module can cause excessive bending and wear of the Acquisition Trunk Cable. If not identified, damaged cables could overheat during use, posing a significant risk of electrical hazards.
There have been no reported injuries or deaths associated with this recall. However, the potential for overheating presents a serious risk.
Stop using the device immediately. Contact GE Medical Systems or your healthcare provider for further instructions on how to proceed with the recall.
For more information, contact GE Medical Systems at 1-800-XXX-XXXX or visit their website at www.gehealthcare.com.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.